Medicamen Biotech (BOM:531146) ROCE % : 8.44% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Medicamen Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medicamen Biotech's annualized ROCE % for the quarter that ended in Dec. 2024 was 8.44%.

Medicamen Biotech ROCE % Historical Data

The historical data trend for Medicamen Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech ROCE % Chart

Medicamen Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

17.43

13.16

13.29

11.44

8.61

Medicamen Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															7.71	8.65	4.31	5.46	8.44

Medicamen Biotech ROCE % Calculation

Medicamen Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	174.728	/	( ( (2785.173 - 825.735)	+	(2945.51 - 845.554) )	/ 2 )
	=	174.728	/	( (1959.438	+	2099.956)	/ 2 )
	=	174.728	/	2029.697
	=	8.61 %

Medicamen Biotech's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	185.46	/	( ( (2885.114 - 687.969)	+	(0 - 0) )	/ 1 )
	=	185.46	/	( ( 2197.145	+	0 )	/ 1 )
	=	185.46	/	2197.145
	=	8.44 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Medicamen Biotech (BOM:531146) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medicamen Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (BOM:531146) » Definitions » ROCE %

Traded in Other Exchanges

MEDICAMEQ:India

Address

1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019

Website

https://www.medicamen.com

Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines